Allergy of Nose

Not yet recruiting

• Conditions: Allergic rhinitis, unspecified,

• Registration Number: CTRI/2022/02/040083
• Lead Sponsor: All India Institute Of medical sciences Department of ENT Head and Neck surgery

Brief Summary

The study would be conducted in the Departments ofOtorhinolaryngology and Head Neck Surgery, Hematology and Endocrinology, AIIMS,New Delhi.

Our study sample would comprise of 100 patients ofallergic rhinitis who would be recruited from the patientsattending  ENT OPD, AIIMS for allergic rhinitis. we would recruitthose who fit the inclusion / exclusion criteria and would be willing toparticipate in the study.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-05-02
• Study Start: 2022-10-02

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Valid informed consent to be enrolled in the study Male or female Age 11 to 60 years Clinically proven cases of Allergic Rhinitis with deficient serum 25 (OH) Vitamin D level.

Exclusion Criteria

Age less than 11 years or more than 60 years History of any major systemic or local medical illnesses, like Uncontrolled diabetes mellitus, Uncontrolled hypertension, Active tuberculosis, liver diseases, inflammatory conditions or any auto-immune disorder, or local pathologies like nasal polyp or nasal mass Those who do not give the consent for participation History of hypersensitivity to steroids Patients with normal level of Serum 25 (OH) Vitamin D level or on supplements Pregnant woman and lactating mothers.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
decrease in SNOT 22 score	Baseline and after 3 months of treatment

Secondary Outcome Measures

Name	Time	Method
decrease in Absolute eosinophil count	3 months

Trial Locations

Locations (1)

AIIMS; 🇮🇳 Delhi, DELHI, India

AIIMS

🇮🇳Delhi, DELHI, India

Dr Shuchita Singh

Principal investigator

9717278897

drshuch@yahoo.com